Establishing Walking-related Digital Biomarkers in Rare Childhood Onset Progressive Neuromuscular Disorders
Part of paid clinical trials in Palo Alto, California.
- Sponsor
- Columbia University
- Study ID
- NCT06839469
- Status
- Recruiting
Conditions
- Duchenne Muscular Dystrophy (DMD)
- Spinal Muscular Atrophy Type 3
Eligibility Criteria
- Sex
- ALL
- Age
- 5 Years - N/A
- Healthy Volunteers
- Accepted
Study Details
The purpose of this research is (1) to identify disease specific walking-related digital biomarkers of disease severity, and (2) monitor longitudinal changes in natural environments, for extended periods of time, in DMD and SMA.
Key Dates
- Start date
- May 1, 2024
- Status verified
- Apr 2026
- Primary completion
- Dec 30, 2027
- Completion
- Apr 1, 2028
Study Design
- Enrollment
- 106 participants (estimated)
Arms
- Arm: Spinal Muscular AtrophyAmbulatory children and adults at least 5 years old by the time of enrollment with genetically confirmed SMA.
- Arm: Duchenne Muscular DystrophyAmbulatory children and adults ages at least 5 years old by the time of enrollment with genetically confirmed Duchenne or Becker muscular dystrophy or evidence on muscle biopsy with a clinical presentation consistent with DMD/BMD.
- Arm: Healthy ControlThe healthy control group will be ambulatory children and adults at least 5 years of age, age- and gender-matched to the SMA and DMD groups as best as possible.
Primary Outcome Measure
Six Minute Walk Test [ Time Frame: One day ]
Central Contacts
- Jacqueline Montes, PT, EdD212-305-8916
- Cara Kanner, DPT516-581-8150
Locations (3)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Stanford University | Palo Alto | California | 94304 | John W Day, MD (PRINCIPAL_INVESTIGATOR) Sally Dunaway Young, PT, DPT (SUB_INVESTIGATOR) |
| Boston Children's Hospital | Boston | Massachusetts | 02115 | Amy Pasternak, PT, DPT (PRINCIPAL_INVESTIGATOR) Maria F Fragala Pinkham, PT, DPT, Dsc (SUB_INVESTIGATOR) |
| Columbia University Irving Medical Center | New York | New York | 10032 |
Find similar trials in Palo Alto, CA
Related Studies
- A Study to Evaluate How Apitegromab Works in Subjects Who Are Less Than 2 Years Old and Have Spinal Muscular AtrophyPHASE2 · Recruiting · Scholar Rock, Inc. · Phoenix, Arizona
- The Baby Duchenne Study: Characterizing Developmental and Clinical Outcomes in the First Three Years in Children With Duchenne Muscular DystrophyRecruiting · University of Rochester · Rochester, New York
- Gait and Bone Health in SMARecruiting · Jacqueline Montes · New York, New York
- Duchenne Electronic Health Record StudyRecruiting · The Duchenne Registry · Little Rock, Arkansas